Related Experiment Videos
T-cell immunodeficiency induced by T-cell mitogens combined with cyclophosphamide injection
T K Kondratyeva1, L N Fontalin, N V Mikheeva
1Gamaleya Institute for Epidemiology and Microbiology, Academy of Medical Sciences, Moscow, Russia.
Immunology Letters
|September 1, 1992
Summary
Cyclophosphamide (CP) combined with T-cell mitogens depletes T-cells, causing immune deficiency. Adoptive transfer of T-cells restores immune function, suggesting polyclonal T-cell deletion as a model for CP-induced tolerance.
Area of Science:
- Immunology
- Cellular Immunology
- Immunosuppression
Background:
- Cyclophosphamide (CP) is an immunosuppressive drug.
- T-cell mitogens stimulate T-lymphocyte proliferation.
- Understanding drug-induced immune modulation is crucial for therapeutic applications.
Purpose of the Study:
- To investigate the effects of combined T-cell mitogen and CP administration on murine immune cells.
- To determine the mechanism behind CP-induced immune suppression in the context of T-cell activation.
- To establish a model for cyclophosphamide-induced tolerance.
Main Methods:
- In vivo administration of T-cell mitogens (LcA, Con A, anti-Thy 1.2 mAb) and cyclophosphamide (CP) in mice.
- Assessment of T-cell subset (Th1, Th2, Ts) and B-cell functional activity.
- Quantification of T-cell counts in the spleen.
- Adoptive transfer of thymocytes to evaluate immune restoration.
Main Results:
- Combined T-cell mitogens and CP significantly inhibited T-cell subset activity and reduced splenic T-cell counts.
- B-cell function remained unaffected.
- Neither T-mitogens nor CP alone produced significant immunosuppression.
- Adoptively transferred thymocytes restored T-dependent responses and did not suppress normal responses to sheep red blood cells (SRBC).
Conclusions:
- The study demonstrates that acquired immune deficiency results from polyclonal elimination of mitogen-stimulated T cells.
- This phenomenon serves as a valuable model for understanding cyclophosphamide-induced tolerance.
- The findings highlight the selective vulnerability of activated T cells to CP in combination with mitogens.